Association between patient-reported financial burden and catastrophic health expenditures in cancer survivors.

Autor: Uppal N; Harvard Medical School, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Broekhuis JM; Harvard Medical School, Boston, MA, USA; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA., Gomez-Mayorga JL; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chen HW; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chaves N; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA., James BC; Harvard Medical School, Boston, MA, USA; Division of Surgical Oncology, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: bjames1@bidmc.harvard.edu.
Jazyk: angličtina
Zdroj: Healthcare (Amsterdam, Netherlands) [Healthc (Amst)] 2024 Dec; Vol. 12 (4), pp. 100752. Date of Electronic Publication: 2024 Sep 23.
DOI: 10.1016/j.hjdsi.2024.100752
Abstrakt: Purpose: To measure rates of patient-reported financial burden, compare them across cancer types, and determine whether they are predictive of catastrophic health expenditures (CHE).
Methods: We extracted data from the Medical Expenditures Panel Survey from 2011 to 2017 to conduct a retrospective population-based cohort study and multivariable logistic regression to assess the financial burden of cancer across 16 cancer types and compare patient-reported metrics to CHE rates.
Results: Patients with ovarian cancer were most likely to report inability paying bills (34.5 %) and filing for bankruptcy (9.4 %), while patients with thyroid cancer were most likely to incur debt (22.4 %). Patients with kidney cancer had the highest mean debt ($46,915). CHEs were independently predicted by inability to pay medical bills (OR [95 % CI], 1.96 [1.14-3.35]) and bankruptcy filing (OR [95 % CI], 3.90 [1.21-12.60].
Conclusions and Implications: We report important variations in the financial burden across cancer types and underscore the importance of assessing how patient-reported measures are related to CHEs.
Policy Implications: The financial burden of cancer care could explain the lack of improved outcomes with increased national health spending.
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Uppal reports receiving income from Quantified Ventures, Ironwood Medical Information Technologies, and BrightEdge unrelated to the submitted work within the 3 years prior to submission.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: